Search
for
Sort by
Research 601–630 of 1000+
- Effectiveness and safety of the ablative fractional 2940-nm Er: YAG laser for the treatment of androgenetic alopecia
- Pilose antler extract promotes hair growth in androgenic alopecia mice by promoting the initial anagen phase
- Investigator‐blinded, controlled, and randomized comparative study on 1565 nm non‐ablative fractional laser versus 5% minoxidil for treatment of androgenetic alopecia
- Progress on the mechanism of natural products alleviating androgenetic alopecia
- Considerations and recommendations on camouflage in alopecia in Black women
- Dual Relief: How Atopic Dermatitis Treatments Affect Alopecia Areata—A Small Retrospective Cohort Study
- Fillers impacting follicles: the emerging complication of filler‐induced alopecia
- Comparative analysis of scalp and gut microbiome in androgenetic alopecia: A Korean cross-sectional study
- JAM-A facilitates hair follicle regeneration in alopecia areata through functioning as ceRNA to protect VCAN expression in dermal papilla cells
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Sustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysis of the ALLEGRO phase 2b/3 trial
- Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
- Patient Perspectives regarding Artificial Intelligence-Driven Trichoscopy for Alopecia Evaluation
- Alopecia areata and adverse pregnancy outcomes: A systematic review and meta-analysis
- The Frontal Fibrosing Alopecia Syndrome: How a Single Word Name Change Might Change So Much
- Topical gabapentin and its relation to cutaneous innervation in symptomatic lymphocytic primary cicatricial alopecia
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- New and Emerging Therapies for Alopecia Areata
- Race and Alopecia Areata amongst US Women
- British Association of Dermatologists living guideline for managing people with alopecia areata 2024
- Hair Follicle-Related MicroRNA-34a Serum Expression and rs2666433A/G Variant in Patients with Alopecia: A Cross-Sectional Analysis
- British Association of Dermatologists living guideline for managing people with alopecia areata 2025
- The Epidemiology of Hospital-Treated Alopecia Areata in Denmark, 1995–2016
- Effectiveness and Predictive Factors of Response to Tofacitinib Therapy in 125 Patients with Alopecia Areata: A Single-centre Real-world Retrospective Study
- Overview of alopecia areata for managed care and payer stakeholders in the United States
- Vitiligo and alopecia areata: apples and oranges?
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Alopecia areata following COVID-19 vaccine: a systematic review
- More is not always better in hair growth factors. epidermal growth factor: hair growth factor involved in alopecia areata pathogenesis
- Dysregulated behaviour of hair follicle stem cells triggers alopecia and provides potential therapeutic targets